Status:
UNKNOWN
Daily Blood Glucose Trends in Patients at Risk for Diabetes
Lead Sponsor:
Karol E. Watson, MD
Collaborating Sponsors:
University of California, Los Angeles
Conditions:
Stress
Blood Sugar; High
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this study is to learn about the relationship between blood sugar, diet, stress, and metabolic parameters including waist circumference, body mass index (BMI), cholesterol levels and blood...
Detailed Description
The relevance of diet, sleep, and stress and their metabolic consequences in cardiovascular risk is principal. Current improvements and developments in food labeling and personal self-tracking devices...
Eligibility Criteria
Inclusion
- Inclusion Criteria (Must meet at least one of the following):
- Overweight and/or obese BMI classification, 25 to 35 kg/m2
- Fasting serum glucose ≥100 mg/dL and \<126 mg/dL or HbA1c \>5.7% and \< 6.5%
- Family history of Type 2 DM
- History of hypertension, hypertriglyceridemia, heart disease, and/or stroke
- History of gestational diabetes
- Exclusion Criteria:
- Any subject currently taking blood thinning medications such as Warfarin or Coumadin
- Any history of gastrointestinal disease or surgery except for appendectomy or cholecystectomy.
- History of gastrointestinal surgery, diabetes mellitus, or other serious medical condition, such as chronic hepatic or renal disease, bleeding disorder, congestive heart disease, chronic diarrhea disorders, myocardial infarction, coronary artery bypass graft, angioplasty within 6 months prior to screening, current diagnosis of uncontrolled hypertension (defined as systolic BP \>160mmHg, diastolic BP \>95mmHg), active or chronic gastrointestinal disorders, bulimia, anorexia, laxative abuse, or endocrine diseases (except thyroid disease requiring medication) as indicated by medical history.
- Pregnant or breastfeeding
- Currently uses tobacco products.
- Currently has an alcohol intake \> 20 g ⁄ day;
- Currently has a coffee intake \> 3 cups ⁄ day;
- Is unable or unwilling to comply with the study protocol.
Exclusion
Key Trial Info
Start Date :
October 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 30 2024
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06000735
Start Date
October 1 2023
End Date
October 30 2024
Last Update
August 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCLA Clinical Nutrition Clinic, 200 UCLA Medical Plaza, Suite 365-C
Los Angeles, California, United States, 90095